These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 18820657)

  • 21. Intravitreal triamcinolone acetonide injection at the end of vitrectomy for diabetic vitreous hemorrhage: a randomized, clinical trial.
    Faghihi H; Taheri A; Farahvash MS; Esfahani MR; Rajabi MT
    Retina; 2008 Oct; 28(9):1241-6. PubMed ID: 18626423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravitreal triamcinolone acetonide treatment of macular edema associated with central retinal vein occlusion.
    Goff MJ; Jumper JM; Yang SS; Fu AD; Johnson RN; McDonald HR; Ai E
    Retina; 2006 Oct; 26(8):896-901. PubMed ID: 17031289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravitreal triamcinolone acetonide for macular oedema owing to retinal vein occlusion.
    Patel PJ; Zaheer I; Karia N
    Eye (Lond); 2008 Jan; 22(1):60-4. PubMed ID: 16902493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic effect of intravitreal injection of triamcinolone in the treatment of endothelial graft rejection: a pilot study.
    You IC; Yoon KC
    Cornea; 2012 Oct; 31(10):1135-40. PubMed ID: 22367049
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subconjunctival triamcinolone for the treatment of corneal graft rejection and new vessels.
    Athanasiadis Y; Novitskaya E; Nithyanandrajah GA; Sharma A
    Cont Lens Anterior Eye; 2009 Feb; 32(1):31-2. PubMed ID: 18693063
    [No Abstract]   [Full Text] [Related]  

  • 26. The use of a single pulse of intravenous methylprednisolone in the treatment of corneal graft rejection. A preliminary report.
    Hill JC; Maske R; Watson PG
    Eye (Lond); 1991; 5 ( Pt 4)():420-4. PubMed ID: 1743357
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravitreal triamcinolone acetonide for treatment of sympathetic ophthalmia.
    Jonas JB
    Am J Ophthalmol; 2004 Feb; 137(2):367-8. PubMed ID: 14962439
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of subconjunctival 5-fluorouracil and triamcinolone injection in impending recurrent pterygium.
    Prabhasawat P; Tesavibul N; Leelapatranura K; Phonjan T
    Ophthalmology; 2006 Jul; 113(7):1102-9. PubMed ID: 16730066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravitreal triamcinolone acetonide for treatment of persistent macular oedema in branch retinal vein occlusion.
    Ozkiris A; Evereklioglu C; Erkilic K; Dogan H
    Eye (Lond); 2006 Jan; 20(1):13-7. PubMed ID: 15723039
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Posterior subtenon and intravitreal triamcinolone acetonide for diabetic macular edema.
    Ozdek S; Bahçeci UA; Gürelik G; Hasanreisoğlu B
    J Diabetes Complications; 2006; 20(4):246-51. PubMed ID: 16798476
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A prospective study of early intraocular pressure changes after a single intravitreal triamcinolone injection.
    Im L; Allingham RR; Singh I; Stinnett S; Fekrat S
    J Glaucoma; 2008 Mar; 17(2):128-32. PubMed ID: 18344759
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of topical cyclosporine 0.05% for prevention of cornea transplant rejection episodes.
    Price MO; Price FW
    Ophthalmology; 2006 Oct; 113(10):1785-90. PubMed ID: 16884779
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of experimental angiogenesis of cornea by various doses of doxycycline and combination of triamcinolone acetonide with low-molecular-weight heparin and doxycycline.
    Aydin E; Kivilcim M; Peyman GA; Esfahani MR; Kazi AA; Sanders DR
    Cornea; 2008 May; 27(4):446-53. PubMed ID: 18434849
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Attenuation of ocular hypertension with the use of topical loteprednol etabonate 0.5% in steroid responders after corneal transplantation.
    Holland EJ; Djalilian AR; Sanderson JP
    Cornea; 2009 Dec; 28(10):1139-43. PubMed ID: 19770719
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective laser trabeculoplasty for intraocular pressure elevation after intravitreal triamcinolone acetonide injection.
    Pizzimenti JJ; Nickerson MM; Pizzimenti CE; Kasten-Aker AG
    Optom Vis Sci; 2006 Jul; 83(7):421-5. PubMed ID: 16840867
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early treatment of severe cystoid macular edema in central retinal vein occlusion with posterior sub-tenon triamcinolone acetonide.
    Lin JM; Chiu YT; Hung PT; Tsai YY
    Retina; 2007 Feb; 27(2):180-9. PubMed ID: 17290200
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative study on efficacy of a combination therapy of triamcinolone acetonide administration with and without vitrectomy for macular edema associated with branch retinal vein occlusion.
    Hirano Y; Sakurai E; Yoshida M; Ogura Y
    Ophthalmic Res; 2007; 39(4):207-12. PubMed ID: 17596753
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Duration of the effect of intravitreal triamcinolone acetonide as treatment for diffuse diabetic macular edema.
    Jonas JB; Degenring RF; Kamppeter BA; Kreissig I; Akkoyun I
    Am J Ophthalmol; 2004 Jul; 138(1):158-60. PubMed ID: 15234306
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of intraocular pressure elevation after anterior versus posterior subtenon triamcinolone acetonide acetate injection: a retrospective study.
    Liu X; Li Y; Zhang Y; Du W; Sun S; Lin B; Chen H; Cheng L
    Retina; 2012 Oct; 32(9):1838-43. PubMed ID: 22487579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Posterior juxtascleral infusion of modified triamcinolone acetonide formulation for refractory diabetic macular edema: one-year follow-up.
    Veritti D; Lanzetta P; Perissin L; Bandello F
    Invest Ophthalmol Vis Sci; 2009 May; 50(5):2391-7. PubMed ID: 19117937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.